SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 771.48+1.2%Jan 27 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: F. Jay Abella, III who wrote (78)4/10/1997 11:35:00 PM
From: Miljenko Zuanic   of 3559
 
F. Jay,

Did you read 10K/96 SEC file. If not, please do it. If there was leak, I think it was, it was from AMGN side leaking info to Smith Barney. Regardless two B+ products AMGN is spoiled company and they appreciate strong coverage from SB. In return..... (IMO).
I have opportunity to sell REGN at 23 (Oct.) and again at 20 before collapse, but I didn't. BDNF is not only reasons to hold REGN share. Signal transduction/cell biochemistry projects are. If it take 3+ years,... so be it.

mz
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News